Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial

NCT01876043 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT01876043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01876043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial
Lead sponsor
Institut Bergonié
Phase
Phase 2
Overall status
Terminated
Start date
February 29, 2012
Completion date
April 30, 2015
Enrollment
24 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

adult patients with unresectable locally advanced or metastatic, relapsed/refractory dedifferentiated liposarcoma